Reliability of Theophylline Clearance in Determining Maintenance Intravenous Aminophylline Therapy
dc.contributor.author | Grambau, Geoffrey R. | en_US |
dc.contributor.author | Johnson, Cary E. | en_US |
dc.contributor.author | Conlon, Paul F. | en_US |
dc.contributor.author | Weg, John G. | en_US |
dc.date.accessioned | 2013-04-08T20:49:40Z | |
dc.date.available | 2013-04-08T20:49:40Z | |
dc.date.issued | 1985-07-08 | en_US |
dc.identifier.citation | Grambau, Geoffrey R.; Johnson, Cary E.; Conlon, Paul F.; Weg, John G. (1985). "Reliability of Theophylline Clearance in Determining Maintenance Intravenous Aminophylline Therapy." The Journal of Clinical Pharmacology 25(5). <http://hdl.handle.net/2027.42/97186> | en_US |
dc.identifier.issn | 0091-2700 | en_US |
dc.identifier.issn | 1552-4604 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/97186 | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Reliability of Theophylline Clearance in Determining Maintenance Intravenous Aminophylline Therapy | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of The University of Michigan Hospitals and The College of Pharmacy | en_US |
dc.contributor.affiliationum | Department of The University of Michigan, Ann Arbor, Ml. | en_US |
dc.contributor.affiliationother | Department of Internal Medicine, Ann Arbor, Ml. | en_US |
dc.contributor.affiliationother | Department of Pharmacy, Ann Arbor, Ml. | en_US |
dc.identifier.pmid | 4031115 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/97186/1/j.1552-4604.1985.tb02859.x.pdf | |
dc.identifier.doi | 10.1002/j.1552-4604.1985.tb02859.x | en_US |
dc.identifier.source | The Journal of Clinical Pharmacology | en_US |
dc.identifier.citedreference | Johnson MH, Burkle WS: Evaluation of the Chiou method for determining theophylline dosages. Clin Pharm, 1984; 3: 174 – 178. | en_US |
dc.identifier.citedreference | Mitenko PA, Ogilvie RI: Rational intravenous doses of theophylline. N Engl J Med, 1973; 289: 600 – 603. | en_US |
dc.identifier.citedreference | Hendeles L, Bighley L, Richardson R, et al: Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm, 1977; 11: 12 – 18. | en_US |
dc.identifier.citedreference | Chiou WL, Gadalla MAF, Peng GW: Method for the rapid estimation of the total body clearance and adjustment of dosage regimens in patients during a constant‐rate intravenous infusion. J Pharmacokinet Biopharm, 1978; 6: 135 – 151. | en_US |
dc.identifier.citedreference | Weinberger MM, Chidsay C: Rapid analysis for theophylline in serum by use of high pressure cation exchange chromatography. Clin Chem, 1975; 21: 834 – 837. | en_US |
dc.identifier.citedreference | Floyd RA, Bartlet LN: Percent theophylline in aminophylline. Drug Intell Clin Pharm, 1978; 12: 177. | en_US |
dc.identifier.citedreference | Hendeles L, Weinberger M, Bighley L: Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis, 1978; 118: 97 – 103. | en_US |
dc.identifier.citedreference | Weinberger MM, Matthey RA, Ginchansay EJ: Intravenous aminophylline dosage: Use of serum theophylline measurement for guidance. JAMA, 1976; 235: 2110 – 2113. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.